These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 11781246)

  • 1. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interleukin 13 in classical Hodgkin lymphoma.
    Skinnider BF; Kapp U; Mak TW
    Leuk Lymphoma; 2002 Jun; 43(6):1203-10. PubMed ID: 12152987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
    Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 13: a growth factor in hodgkin lymphoma.
    Skinnider BF; Kapp U; Mak TW
    Int Arch Allergy Immunol; 2001 Dec; 126(4):267-76. PubMed ID: 11815733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphomagenesis in Hodgkin lymphoma.
    Matsuki E; Younes A
    Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of Hodgkin lymphoma.
    Küppers R
    Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity.
    Hinz M; Lemke P; Anagnostopoulos I; Hacker C; Krappmann D; Mathas S; Dörken B; Zenke M; Stein H; Scheidereit C
    J Exp Med; 2002 Sep; 196(5):605-17. PubMed ID: 12208876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
    Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
    Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.
    Oshima Y; Puri RK
    Cell Immunol; 2001 Jul; 211(1):37-42. PubMed ID: 11585386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.
    Stanelle J; Döring C; Hansmann ML; Küppers R
    Blood; 2010 Nov; 116(20):4202-11. PubMed ID: 20660789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
    Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
    J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.
    Trieu Y; Wen XY; Skinnider BF; Bray MR; Li Z; Claudio JO; Masih-Khan E; Zhu YX; Trudel S; McCart JA; Mak TW; Stewart AK
    Cancer Res; 2004 May; 64(9):3271-5. PubMed ID: 15126369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.
    Zhou M; Fadlelmola FM; Cohn JB; Skinnider B; Gascoyne RD; Banerjee D
    Mol Cancer; 2008 Jan; 7():12. PubMed ID: 18218123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
    Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
    Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
    Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
    Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 is constitutively activated in Hodgkin cell lines.
    Kube D; Holtick U; Vockerodt M; Ahmadi T; Haier B; Behrmann I; Heinrich PC; Diehl V; Tesch H
    Blood; 2001 Aug; 98(3):762-70. PubMed ID: 11468177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
    Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
    Blood; 2011 Jan; 117(1):165-74. PubMed ID: 20876453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center.
    Tinguely M; Rosenquist R; Sundström C; Amini RM; Küppers R; Hansmann ML; Bräuninger A
    Am J Surg Pathol; 2003 Nov; 27(11):1483-8. PubMed ID: 14576485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine expression in Reed-Sternberg cells of Hodgkin's disease.
    Kato H; Watanabe K; Murari M; Isogai C; Kinoshita T; Nagai H; Ohashi H; Nagasaka T; Kadomatsu K; Muramatsu H; Muramatsu T; Saito H; Mori N; Murate T
    Leuk Lymphoma; 2000 Apr; 37(3-4):415-24. PubMed ID: 10752993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.